0

Hypertrophic Cardiomyopathy Top 10

Click below to access your content. Once you have successfully completed this course your certificate will become available at the top of this page and on your My Certificates page.

Course Details

Credit/contact hours: .25 hours
Estimated time to complete: 20 minutes
Publication Date: March 8, 2018
Expiration date: March 7, 2021
Reviewed:

Description:

Hypertrophic cardiomyopathy is an uncommon disorder of cardiac muscle typically on a genetic basis; however, the relationship of specific genotypes to clinical presentation is complex and still poorly characterized. Hypertrophic cardiomyopathy can be associated with outflow track obstruction, heart failure, and arrhythmias – it thus presents an important diagnostic and therapeutic challenge to the managing physicians. The physiology is complex, but has major implications for the patient’s lifestyle, ability to tolerate surgery, and life expectancy.

You Will Learn

  • To describe the hemodynamic abnormalities that can occur with the various forms of hypertrophic cardiomyopathy.
  • To enumerate medications that are specifically indicated, and those that are specifically contra-indicated, in the various forms of hypertrophic cardiomyopathy.
  • To define patient subsets who that might be appropriate for alcohol septal ablation, surgical myomectomy, or placement of an automatic implantable cardioverter defibrillator (AICD).

Method and medium:

Learners participate in the interactive learning modules by correctly answering multiple choice questions dispersed throughout. Learners will be prompted to try again if a question is answered incorrectly.The course will open in a new tab - to exit the course, simply close that tab.

Michael Ragosta III, MD

Dr. Michael Ragosta is an attending cardiologist at the University of Virginia Health System with a sub-specialty in interventional cardiology. His clinical practice includes complex percutaneous coronary intervention, myocardial infarction, valvular heart disease, structural heart disease, and general cardiology. Dr. Ragosta is the Director of the Cardiac Catheterization Laboratories at UVA and author of numerous textbooks related to cardiac catheterization and hemodynamic interpretation.

DISCLOSURE: This individual reports no relevant financial relationships with commercial entities.

Please rate this


 5/5 (3)